By Professor Glenda Halliday

Journal articles

Foxe D; Hu A; Cheung SC; Ahmed RM; Cordato NJ; Devenney E; Hwang YT; Halliday GM; Mueller N; Leyton CE; Hodges JR; Burrell JR; Irish M; Piguet O, 2022, 'Utility of the Addenbrooke's Cognitive Examination III online calculator to differentiate the primary progressive aphasia variants', BRAIN COMMUNICATIONS, 4, http://dx.doi.org/10.1093/braincomms/fcac161

Phillips JR; Matar E; Ehgoetz Martens KA; Moustafa AA; Halliday GM; Lewis SJG, 2022, 'An Adaptive Measure of Visuospatial Impairment in Dementia with Lewy Bodies', Movement Disorders Clinical Practice, 9, pp. 619 - 627, http://dx.doi.org/10.1002/mdc3.13488

Weiss F; Labrador-Garrido A; Dzamko N; Halliday G, 2022, 'Immune responses in the Parkinson's disease brain', Neurobiology of Disease, 168, http://dx.doi.org/10.1016/j.nbd.2022.105700

Wenning GK; Stankovic I; Vignatelli L; Fanciulli A; Calandra-Buonaura G; Seppi K; Palma JA; Meissner WG; Krismer F; Berg D; Cortelli P; Freeman R; Halliday G; Höglinger G; Lang A; Ling H; Litvan I; Low P; Miki Y; Panicker J; Pellecchia MT; Quinn N; Sakakibara R; Stamelou M; Tolosa E; Tsuji S; Warner T; Poewe W; Kaufmann H, 2022, 'The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy', Movement Disorders, 37, pp. 1131 - 1148, http://dx.doi.org/10.1002/mds.29005

Katzeff JS; Bright F; Phan K; Kril JJ; Ittner LM; Kassiou M; Hodges JR; Piguet O; Kiernan MC; Halliday GM; Kim WS, 2022, 'Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis', Brain, 145, pp. 1598 - 1609, http://dx.doi.org/10.1093/brain/awac077

Boel JA; de Bie RMA; Schmand BA; Dalrymple-Alford JC; Marras C; Adler CH; Goldman JG; Tröster AI; Burn DJ; Litvan I; Geurtsen GJ; Bernard B; Stebbins G; Filoteo JV; Weintraub D; Caviness JN; Belden C; Zabetian CP; Cholerton BA; Huang X; Eslinger PJ; Leverenz JB; Duff-Canning S; Farrer M; Anderson TJ; Myall DJ; Naismith SL; Lewis SJG; Halliday GM; Wu RM; Williams-Gray CH; Breen DP; Barker RA; Yarnall AJ; Klein M; Mollenhauer B; Trenkwalder C; Kulisevsky J; Pagonabarraga J; Gasca-Salas C; Rodriguez-Oroz MC; Junque C; Segura B; Barone P; Santangelo G; Cammisuli DM; Biundo R; Antonini A; Weis L; Pedersen KF; Alves G, 2022, 'Level I PD-MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia', Movement Disorders Clinical Practice, 9, pp. 479 - 483, http://dx.doi.org/10.1002/mdc3.13451

Hooshmand K; Halliday GM; Pineda SS; Sutherland GT; Guennewig B, 2022, 'Overlap between Central and Peripheral Transcriptomes in Parkinson’s Disease but Not Alzheimer’s Disease', International Journal of Molecular Sciences, 23, http://dx.doi.org/10.3390/ijms23095200

Chen Y; Landin-Romero R; Kumfor F; Irish M; Dobson-Stone C; Kwok JB; Halliday GM; Hodges JR; Piguet O, 2022, 'Cerebellar integrity and contributions to cognition in C9orf72-mediated frontotemporal dementia', Cortex, 149, pp. 73 - 84, http://dx.doi.org/10.1016/j.cortex.2021.12.014

Matar E; Brooks D; Lewis SJG; Halliday GM, 2022, 'Limbic thalamus atrophy is associated with visual hallucinations in Lewy body disorders', Neurobiology of Aging, 112, pp. 122 - 128, http://dx.doi.org/10.1016/j.neurobiolaging.2022.01.001

Stevanovski I; Chintalaphani SR; Gamaarachchi H; Ferguson JM; Pineda SS; Scriba CK; Tchan M; Fung V; Ng K; Cortese A; Houlden H; Dobson-Stone C; Fitzpatrick L; Halliday G; Ravenscroft G; Davis MR; Laing NG; Fellner A; Kennerson M; Kumar KR; Deveson IW, 2022, 'Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing', Science Advances, 8, http://dx.doi.org/10.1126/sciadv.abm5386

Ferreira N; Richner M; van der Laan A; Jul Christiansen IB; Vaegter CB; Nyengaard JR; Halliday GM; Weis J; Giasson BI; Mackenzie IR; Jensen PH; Jan A, 2022, 'Correction: Prodromal neuroinvasion of pathological alpha-synuclein in brainstem reticular nuclei and white matter lesions in a model of alpha-synucleinopathy (vol 3, fcab104, 2021)', BRAIN COMMUNICATIONS, 4, http://dx.doi.org/10.1093/braincomms/fcac067

Bocchetta M; Todd EG; Tse NY; Devenney EM; Tu S; Caga J; Hodges JR; Halliday GM; Irish M; Piguet O; Kiernan MC; Rohrer JD; Ahmed RM, 2022, 'Thalamic and Cerebellar Regional Involvement across the ALS–FTD Spectrum and the Effect of C9orf72', Brain Sciences, 12, http://dx.doi.org/10.3390/brainsci12030336

Ge P; Yang M; Bouchard JL; Dzamko N; Lewis SJG; Halliday GM; Doran TM, 2022, 'Chemoselective Bioconjugation of Amyloidogenic Protein Antigens to PEGylated Microspheres Enables Detection of α-Synuclein Autoantibodies in Human Plasma', Bioconjugate Chemistry, 33, pp. 301 - 310, http://dx.doi.org/10.1021/acs.bioconjchem.1c00530

Narasimhan M; Schwartz R; Halliday G, 2022, 'Parkinsonism and cerebrovascular disease', Journal of the Neurological Sciences, 433, http://dx.doi.org/10.1016/j.jns.2021.120011

Kumfor F; Liang CT; Hazelton JL; Leyton CE; Kaizik C; Devenney E; Connaughton E; Langdon R; Mioshi E; Kwok JB; Dobson-Stone C; Halliday GM; Piguet O; Hodges JR; Landin-Romero R, 2022, 'Examining the presence and nature of delusions in Alzheimer's disease and frontotemporal dementia syndromes', International Journal of Geriatric Psychiatry, 37, http://dx.doi.org/10.1002/gps.5692

Ehgoetz Martens KA; Matar E; Phillips JR; Shine JM; Grunstein RR; Halliday GM; Lewis SJG, 2022, 'Narrow doorways alter brain connectivity and step patterns in isolated REM sleep behaviour disorder', NeuroImage: Clinical, 33, http://dx.doi.org/10.1016/j.nicl.2022.102958

Mccann H; Bahar AY; Burkhardt K; Gardner AJ; Halliday GM; Iverson GL; Shepherd CE, 2022, 'Prevalence of chronic traumatic encephalopathy in the Sydney Brain Bank', Brain Communications, 4, pp. fcac189, http://dx.doi.org/10.1093/braincomms/fcac189

Fu Y; He Y; Phan K; Pickford R; Kim YB; Dzamko N; Halliday GM; Kim WS, 2022, 'Sex-specific lipid dysregulation in the Abca7 knockout mouse brain', Brain Communications, 4, http://dx.doi.org/10.1093/braincomms/fcac120

de Boer SCM; Riedl L; Van der lee SJ; Otto M; Anderl‐Straub S; Landin‐Romero R; Sorrentino F; Fieldhouse JLP; Reus LM; Halliday GM; Galimberti D; Diehl‐Schmid J; Ducharme S; Piguet O; Pijnenburg YAL, 2022, 'Shorter disease duration in females with sporadic frontotemporal dementia', Alzheimer's & Dementia, 18, http://dx.doi.org/10.1002/alz.067557

Phan K; He Y; Fu Y; Dzamko N; Bhatia S; Gold J; Rowe D; Ke YD; Ittner LM; Hodges JR; Piguet O; Kiernan MC; Halliday GM; Kim WS, 2021, 'Pathological manifestation of human endogenous retrovirus K in frontotemporal dementia', COMMUNICATIONS MEDICINE, 1, http://dx.doi.org/10.1038/s43856-021-00060-w

Phan K; He Y; Fu Y; Dzamko N; Bhatia S; Gold J; Rowe D; Ke YD; Ittner LM; Hodges JR; Piguet O; Kiernan MC; Halliday GM; Kim WS, 2021, 'Pathological manifestation of human endogenous retrovirus K in frontotemporal dementia.', Commun Med (Lond), 1, pp. 60, http://dx.doi.org/10.1038/s43856-021-00060-w

Gregersen E; Betzer C; Kim WS; Kovacs G; Reimer L; Halliday GM; Thiel S; Jensen PH, 2021, 'Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity', Journal of Neuroinflammation, 18, http://dx.doi.org/10.1186/s12974-021-02225-9

Oliveira LMA; Gasser T; Edwards R; Zweckstetter M; Melki R; Stefanis L; Lashuel HA; Sulzer D; Vekrellis K; Halliday GM; Tomlinson JJ; Schlossmacher M; Jensen PH; Schulze-Hentrich J; Riess O; Hirst WD; El-Agnaf O; Mollenhauer B; Lansbury P; Outeiro TF, 2021, 'Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease', npj Parkinson's Disease, 7, http://dx.doi.org/10.1038/s41531-021-00203-9

Guennewig B; Lim J; Marshall L; McCorkindale AN; Paasila PJ; Patrick E; Kril JJ; Halliday GM; Cooper AA; Sutherland GT, 2021, 'Author Correction: Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology (Scientific Reports, (2021), 11, 1, (4865), 10.1038/s41598-021-83872-z)', Scientific Reports, 11, http://dx.doi.org/10.1038/s41598-021-97076-y

Aarsland D; Batzu L; Halliday GM; Geurtsen GJ; Ballard C; Ray Chaudhuri K; Weintraub D, 2021, 'Author Correction: Parkinson disease-associated cognitive impairment (Nature Reviews Disease Primers, (2021), 7, 1, (47), 10.1038/s41572-021-00280-3)', Nature Reviews Disease Primers, 7, http://dx.doi.org/10.1038/s41572-021-00292-z

Guennewig B; Lim J; Marshall L; McCorkindale AN; Paasila PJ; Patrick E; Kril JJ; Halliday GM; Cooper AA; Sutherland GT, 2021, 'Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology', Scientific Reports, 11, http://dx.doi.org/10.1038/s41598-021-83872-z

He Y; Phan K; Bhatia S; Pickford R; Fu YH; Yang Y; Hodges JR; Piguet O; Halliday GM; Kim WS, 2021, 'Increased VLCFA-lipids and ELOVL4 underlie neurodegeneration in frontotemporal dementia', Scientific Reports, 11, http://dx.doi.org/10.1038/s41598-021-00870-x

Gabery S; Ahmed RM; Caga J; Kiernan MC; Halliday GM; Petersén Å, 2021, 'Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis', Neuropathology and Applied Neurobiology, 47, pp. 979 - 989, http://dx.doi.org/10.1111/nan.12709

Nabais MF; Laws SM; Lin T; Vallerga CL; Armstrong NJ; Blair IP; Kwok JB; Mather KA; Mellick GD; Sachdev PS; Wallace L; Henders AK; Zwamborn RAJ; Hop PJ; Lunnon K; Pishva E; Roubroeks JAY; Soininen H; Tsolaki M; Mecocci P; Lovestone S; Kłoszewska I; Vellas B; Furlong S; Garton FC; Henderson RD; Mathers S; McCombe PA; Needham M; Ngo ST; Nicholson G; Pamphlett R; Rowe DB; Steyn FJ; Williams KL; Anderson TJ; Bentley SR; Dalrymple-Alford J; Fowder J; Gratten J; Halliday G; Hickie IB; Kennedy M; Lewis SJG; Montgomery GW; Pearson J; Pitcher TL; Silburn P; Zhang F; Visscher PM; Yang J; Stevenson AJ; Hillary RF; Marioni RE; Harris SE; Deary IJ; Jones AR; Shatunov A; Iacoangeli A; van Rheenen W; van den Berg LH; Shaw PJ; Shaw CE; Morrison KE; Al-Chalabi A; Veldink JH; Hannon E; Mill J; Wray NR; McRae AF, 2021, 'Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders', Genome Biology, 22, http://dx.doi.org/10.1186/s13059-021-02275-5

Aarsland D; Batzu L; Halliday GM; Geurtsen GJ; Ballard C; Ray Chaudhuri K; Weintraub D, 2021, 'Parkinson disease-associated cognitive impairment', Nature Reviews Disease Primers, 7, http://dx.doi.org/10.1038/s41572-021-00280-3

Devenney EM; McErlean K; Tse NY; Caga J; Dharmadasa T; Huynh W; Mahoney CJ; Zoing M; Mazumder S; Dobson-Stone C; Kwok JB; Halliday GM; Hodges JR; Piguet O; Ahmed RM; Kiernan MC, 2021, 'Factors That Influence Non-Motor Impairment Across the ALS-FTD Spectrum: Impact of Phenotype, Sex, Age, Onset and Disease Stage', Frontiers in Neurology, 12, http://dx.doi.org/10.3389/fneur.2021.743688

Long Z; Irish M; Hodges JR; Halliday G; Piguet O; Burrell JR, 2021, 'Amyotrophic lateral sclerosis features predict TDP-43 pathology in frontotemporal lobar degeneration', Neurobiology of Aging, 107, pp. 11 - 20, http://dx.doi.org/10.1016/j.neurobiolaging.2021.07.004

Gabery S; Kwa JE; Cheong RY; Baldo B; Ferrari Bardile C; Tan B; McLean C; Georgiou-Karistianis N; Poudel GR; Halliday G; Pouladi MA; Petersén Å, 2021, 'Early white matter pathology in the fornix of the limbic system in Huntington disease', Acta Neuropathologica, 142, pp. 791 - 806, http://dx.doi.org/10.1007/s00401-021-02362-8

Weissleder C; North HF; Bitar M; Fullerton JM; Sager R; Barry G; Piper M; Halliday GM; Webster MJ; Shannon Weickert C, 2021, 'Reduced adult neurogenesis is associated with increased macrophages in the subependymal zone in schizophrenia', Molecular Psychiatry, 26, pp. 6880 - 6895, http://dx.doi.org/10.1038/s41380-021-01149-3

Matar E; White SR; Taylor JP; Thomas A; Mckeith IG; Kane JPM; Surendranathan A; Halliday GM; Lewis SJG; O'Brien JT, 2021, 'Progression of Clinical Features in Lewy Body Dementia Can Be Detected Over 6 Months', Neurology, 97, pp. E1031 - E1040, http://dx.doi.org/10.1212/WNL.0000000000012450

Huynh B; Fu Y; Kirik D; Shine JM; Halliday GM, 2021, 'Comparison of Locus Coeruleus Pathology with Nigral and Forebrain Pathology in Parkinson's Disease', Movement Disorders, 36, pp. 2085 - 2093, http://dx.doi.org/10.1002/mds.28615

Bright F; Katzeff JS; Hodges JR; Piguet O; Kril JJ; Halliday GM; Kim WS, 2021, 'Glycoprotein Pathways Altered in Frontotemporal Dementia With Autoimmune Disease', Frontiers in Immunology, 12, http://dx.doi.org/10.3389/fimmu.2021.736260

Drouyer M; Bolliger MF; Lobbestael E; Van den Haute C; Emanuele M; Lefebvre R; Sibran W; De Wit T; Leghay C; Mutez E; Dzamko N; Halliday GM; Murayama S; Martoriati A; Cailliau K; Bodart JF; Chartier-Harlin MC; Baekelandt V; Nichols RJ; Taymans JM, 2021, 'Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulation', Neurobiology of Disease, 157, http://dx.doi.org/10.1016/j.nbd.2021.105426

Barbier M; Camuzat A; El Hachimi K; Guegan J; Rinaldi D; Lattante S; Houot M; Sánchez-Valle R; Sabatelli M; Antonell A; Molina-Porcel L; Clot F; Couratier P; van der Ende E; van der Zee J; Manzoni C; Camu W; Cazeneuve C; Sellal F; Didic M; Golfier V; Pasquier F; Duyckaerts C; Rossi G; Bruni AC; Alvarez V; Gómez-Tortosa E; de Mendonça A; Graff C; Masellis M; Nacmias B; Oumoussa BM; Jornea L; Forlani S; van Deerlin V; Rohrer JD; Gelpi E; Rademakers R; van Swieten J; Le Guern E; van Broeckhoven C; Ferrari R; Génin E; Brice A; Le Ber I; Auriacombe S; Belliard S; Bertrand A; Bissery A; Blanc F; Boncoeur MP; Bombois S; Boutoleau-Bretonnière C; Ceccaldi M; Chupin M; Colliot O; Deramecourt V; Dubois B; Etcharry-Bouyx F; Guignebert-Funkiewiez A; Formaglio M; Habert MO; Hannequin D; Lacomblez L; Lagarde J; Lautrette G; Le Toullec B; Levy R; Mackowiak MA; Michel BF; Lebouvier T; Roué-Jagot C; Thauvin-Robinet C; Thomas-Anterion C; Pariente J; Salachas F; Sayah S; Oya AH; Rollin-Sillaire A; Vercelletto M; Wallon D; Rametti-Lacroux A; Hernandez DG; Nalls MA; Ramasamy A; Kwok JBJ; Dobson-Stone C; Brooks WS; Schofield PR; Halliday GM; Hodges JR; Piguet O; Bartley L; Thompson E; Hernández I; Ruiz A; Boada M; Borroni B; Padovani A; Cruchaga C, 2021, 'SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degeneration', Brain, 144, pp. 2798 - 2811, http://dx.doi.org/10.1093/brain/awab171

Roudeau S; Trist BG; Carmona A; Davies KM; Halliday GM; Rufin Y; Claverol S; Van Malderen SJM; Falkenberg G; Double KL; Ortega R, 2021, 'Native Separation and Metallation Analysis of SOD1 Protein from the Human Central Nervous System: A Methodological Workflow', Analytical Chemistry, 93, pp. 11108 - 11115, http://dx.doi.org/10.1021/acs.analchem.1c01128

Devenney EM; Tu S; Caga J; Ahmed RM; Ramsey E; Zoing M; Kwok J; Halliday GM; Piguet O; Hodges JR; Kiernan MC, 2021, 'Neural mechanisms of psychosis vulnerability and perceptual abnormalities in the ALS-FTD spectrum', Annals of Clinical and Translational Neurology, 8, pp. 1576 - 1591, http://dx.doi.org/10.1002/acn3.51363

Li W; Fu YH; Halliday GM; Sue CM, 2021, 'PARK Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson’s Disease', Frontiers in Cell and Developmental Biology, 9, http://dx.doi.org/10.3389/fcell.2021.612476

Muller AJ; Shine JM; Rolle CE; Chitty K; Hall JM; Halliday GM; Hermens DF; Lewis SJG; O’Callaghan C, 2021, 'Anterior-posterior electrophysiological activity characterizes Parkinsonian visual misperceptions', Neurology and Clinical Neuroscience, 9, pp. 312 - 318, http://dx.doi.org/10.1111/ncn3.12508

Forrest SL; Kim JH; De Sousa C; Cheong R; Crockford DR; Sheedy D; Stevens J; McCrossin T; Tan RH; McCann H; Shepherd CE; Rowe DB; Kiernan MC; Halliday GM; Kril JJ, 2021, 'Coexisting Lewy body disease and clinical parkinsonism in amyotrophic lateral sclerosis', European Journal of Neurology, 28, pp. 2192 - 2199, http://dx.doi.org/10.1111/ene.14849

Forrest SL; Shepherd CE; McCann H; Kwok JB; Halliday GM; Kril JJ, 2021, 'Globular glial tauopathy with a mutation in MAPT and unusual TDP-43 proteinopathy in a patient with behavioural-variant frontotemporal dementia', Acta Neuropathologica, 141, pp. 791 - 794, http://dx.doi.org/10.1007/s00401-021-02297-0

Reus LM; Pasaniuc B; Posthuma D; Boltz T; Ferrari R; Hernandez DG; Nalls MA; Rohrer JD; Ramasamy A; Kwok JBJ; Dobson-Stone C; Brooks WS; Schofield PR; Halliday GM; Hodges JR; Piguet O; Bartley L; Thompson E; Hernández I; Ruiz A; Boada M; Borroni B; Padovani A; Cruchaga C; Cairns NJ; Benussi L; Binetti G; Ghidoni R; Forloni G; Galimberti D; Fenoglio C; Serpente M; Scarpini E; Clarimón J; Lleó A; Blesa R; Waldö ML; Nilsson K; Nilsson C; Mackenzie IRA; Hsiung GYR; Mann DMA; Grafman J; Morris CM; Attems J; Griffiths TD; McKeith IG; Thomas AJ; Pietrini P; Huey ED; Wassermann EM; Baborie A; Jaros E; Tierney MC; Pastor P; Razquin C; Ortega-Cubero S; Alonso E; Perneczky R; Diehl-Schmid J; Alexopoulos P; Kurz A; Rainero I; Rubino E; Pinessi L; Rogaeva E; St. George-Hyslop P; Rossi G; Tagliavini F; Giaccone G; Rowe JB; Schlachetzki JCM; Uphill J; Collinge J; Mead S; Danek A; Van Deerlin VM; Grossman M; Trojanowski JQ; van der Zee J; Van Broeckhoven C; Cappa SF; Le Ber I; Hannequin D; Golfier V; Vercelletto M; Brice A; Nacmias B; Sorbi S; Bagnoli S; Piaceri I; Nielsen JE; Hjermind LE; Riemenschneider M; Mayhaus M; Ibach B; Gasparoni G; Pichler S; Gu W; Rossor MN, 2021, 'Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes', Biological Psychiatry, 89, pp. 825 - 835, http://dx.doi.org/10.1016/j.biopsych.2020.12.023

Huynh K; Piguet O; Kwok J; Dobson-Stone C; Halliday GM; Hodges JR; Landin-Romero R, 2021, 'Clinical and Biological Correlates of White Matter Hyperintensities in Patients With Behavioral-Variant Frontotemporal Dementia and Alzheimer Disease', Neurology, 96, pp. E1743 - E1754, http://dx.doi.org/10.1212/WNL.0000000000011638

Chia R; Sabir MS; Bandres-Ciga S; Saez-Atienzar S; Reynolds RH; Gustavsson E; Walton RL; Ahmed S; Viollet C; Ding J; Makarious MB; Diez-Fairen M; Portley MK; Shah Z; Abramzon Y; Hernandez DG; Blauwendraat C; Stone DJ; Eicher J; Parkkinen L; Ansorge O; Clark L; Honig LS; Marder K; Lemstra A; St George-Hyslop P; Londos E; Morgan K; Lashley T; Warner TT; Jaunmuktane Z; Galasko D; Santana I; Tienari PJ; Myllykangas L; Oinas M; Cairns NJ; Morris JC; Halliday GM; Van Deerlin VM; Trojanowski JQ; Grassano M; Calvo A; Mora G; Canosa A; Floris G; Bohannan RC; Brett F; Gan-Or Z; Geiger JT; Moore A; May P; Krüger R; Goldstein DS; Lopez G; Tayebi N; Sidransky E; Sotis AR; Sukumar G; Alba C; Lott N; Martinez EMG; Tuck M; Singh J; Bacikova D; Zhang X; Hupalo DN; Adeleye A; Wilkerson MD; Pollard HB; Norcliffe-Kaufmann L; Palma JA; Kaufmann H; Shakkottai VG; Perkins M; Newell KL; Gasser T; Schulte C; Landi F; Salvi E; Cusi D; Masliah E; Kim RC; Caraway CA; Monuki ES; Brunetti M; Dawson TM; Rosenthal LS; Albert MS; Pletnikova O; Troncoso JC; Flanagan ME; Mao Q; Bigio EH; Rodríguez-Rodríguez E; Infante J; Lage C; González-Aramburu I; Sanchez-Juan P; Ghetti B, 2021, 'Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture', Nature Genetics, 53, pp. 294 - 303, http://dx.doi.org/10.1038/s41588-021-00785-3

Attems J; Toledo JB; Walker L; Gelpi E; Gentleman S; Halliday G; Hortobagyi T; Jellinger K; Kovacs GG; Lee EB; Love S; McAleese KE; Nelson PT; Neumann M; Parkkinen L; Polvikoski T; Sikorska B; Smith C; Grinberg LT; Thal DR; Trojanowski JQ; McKeith IG, 2021, 'Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study', Acta Neuropathologica, 141, pp. 159 - 172, http://dx.doi.org/10.1007/s00401-020-02255-2

Youssef P; Kim WS; Halliday GM; Lewis SJG; Dzamko N, 2021, 'Comparison of Different Platform Immunoassays for the Measurement of Plasma Alpha-Synuclein in Parkinson's Disease Patients', Journal of Parkinson's Disease, 11, pp. 1761 - 1772, http://dx.doi.org/10.3233/jpd-212694

Back to profile page